Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer-Reference-Cited by-同舟云学术

Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer

Published:2022-05 Issue:1 Volume:113 Page:117-124
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bellon Jennifer R.,Tayob Nabihah,Yang David D.,Tralins Jordan,Dang Chau T.,Isakoff Steven J.,DeMeo Michelle,Burstein Harold J.,Partridge Ann H.,Winer Eric P.,Krop Ian E.,Tolaney Sara M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer;Witton;J Pathol,2003

2. c-erbB-2 oncoprotein expression in primary and advanced breast cancer;Lovekin;Br J Cancer,1991

3. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

4. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

5. Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer;McArthur;Cancer,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on the State of the Art of Breast Cancers in Italy;Current Medicinal Chemistry;2024-06

2. Efficacy and safety of Trastuzumab Emtansine in treating human epidermal growth factor receptor 2-positive metastatic breast cancer in Chinese population: a real-world multicenter study;Frontiers in Medicine;2024-04-29

3. Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance;Biomedicines;2024-04-25

4. The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study;Cancers;2024-04-25

5. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates;Critical Reviews in Oncology/Hematology;2024-03